Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization

V Klenerova, I Krejci, P Sida, Z Hlinak, S Hynie

. 2008 ; 432 (3) : 202-205.

Language English Country Ireland

E-resources Online

NLK ScienceDirect (archiv) from 1993-01-01 to 2009-12-31

2mg/kg melanotan II (MTII, administered i.p.), a cyclic peptide analog of alpha-melanocyte stimulating hormone, at a single dose increased grooming in naive rats placed in an unfamiliar open-field device without changing locomotion or rearing. Male rats exposed to restraint/immobilization stress (IS) for 1h on three consecutive days displayed increased grooming after the second stressor exposure, compared to pre-stress levels. MTII, administered to the rats after IS, enhanced the grooming response compared both to the pre- and post-stress values. The increase was greatest after the first dose and declined over the following two applications. As to the locomotion of rats in the entire experimental space, IS reduced the distance moved only after the first two stressor exposures; MTII did not influence these alterations. Locomotion in the central part of arena was not reduced by the stressor or by MTII, on the contrary, there was an increase in both groups after the third intervention. The only observed change in rearing was an increase in the MTII group after the third restraint exposure. Thus, MTII selectively increased grooming without markedly affecting the spatio-temporal structure of locomotor behavior in the open-field. The decline of MTII enhanced grooming over the three test days may be interpreted in terms of adaptation to the stressor and of the developing tolerance to the peptide.

000      
03109naa 2200433 a 4500
001      
bmc11003204
003      
CZ-PrNML
005      
20111210202238.0
008      
110225s2008 ie e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Klenerová, Věra, $d 1940- $7 nlk19990073368
245    10
$a Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization / $c V Klenerova, I Krejci, P Sida, Z Hlinak, S Hynie
314    __
$a Laboratory of Biochemical Neuropharmacology, Medical Biochemistry, First Faculty of Medicine, Charles University in Prague, Albertov 4, 128 00 Prague 2, Czech Republic.
520    9_
$a 2mg/kg melanotan II (MTII, administered i.p.), a cyclic peptide analog of alpha-melanocyte stimulating hormone, at a single dose increased grooming in naive rats placed in an unfamiliar open-field device without changing locomotion or rearing. Male rats exposed to restraint/immobilization stress (IS) for 1h on three consecutive days displayed increased grooming after the second stressor exposure, compared to pre-stress levels. MTII, administered to the rats after IS, enhanced the grooming response compared both to the pre- and post-stress values. The increase was greatest after the first dose and declined over the following two applications. As to the locomotion of rats in the entire experimental space, IS reduced the distance moved only after the first two stressor exposures; MTII did not influence these alterations. Locomotion in the central part of arena was not reduced by the stressor or by MTII, on the contrary, there was an increase in both groups after the third intervention. The only observed change in rearing was an increase in the MTII group after the third restraint exposure. Thus, MTII selectively increased grooming without markedly affecting the spatio-temporal structure of locomotor behavior in the open-field. The decline of MTII enhanced grooming over the three test days may be interpreted in terms of adaptation to the stressor and of the developing tolerance to the peptide.
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $7 D001522
650    _2
$a pátrací chování $x fyziologie $x účinky léků $7 D005106
650    _2
$a péče o zevnějšek u zvířat $x fyziologie $x účinky léků $7 D006120
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanokortiny $x antagonisté a inhibitory $7 D053486
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a cyklické peptidy $x farmakologie $7 D010456
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a fyzické omezení $7 D012149
650    _2
$a alfa-MSH $x analogy a deriváty $x farmakologie $7 D000521
700    1_
$a Krejčí, Ivan $7 xx0097183
700    1_
$a Šída, Pavel. $7 xx0181079
700    1_
$a Hliňák, Zdeněk $7 xx0074045
700    1_
$a Hynie, Sixtus, $d 1933- $7 jk01043454
773    0_
$t Neuroscience Letters $w MED00003507 $g Roč. 432, č. 3 (2008), s. 202-205 $x 0304-3940
910    __
$a ABA008 $b x $y 7
990    __
$a 20110413120333 $b ABA008
991    __
$a 20110413120339 $b ABA008
999    __
$a ok $b bmc $g 830559 $s 695197
BAS    __
$a 3
BMC    __
$a 2008 $b 432 $c 3 $d 202-205 $i 0304-3940 $m Neuroscience letters $n Neurosci. lett. $x MED00003507
LZP    __
$a 2011-2B/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...